Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 1 2Phase NA 1Phase 4 1

Status

Terminated 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 2

Conditions

Solitary Pulmonary Nodule 1Carcinoma, Non-Small-Cell Lung 1Bronchial Neoplasms 1

Interventions

Cisplatin 1519Carboplatin 1420Cyclophosphamide 1360Gemcitabine 1235Bevacizumab 1226Paclitaxel 1211Radiotherapy 1176Docetaxel 1080pembrolizumab 1028Oxaliplatin 936Capecitabine 901Fluorouracil 833Rituximab 729Doxorubicin 683Nivolumab 679Dexamethasone 666Etoposide 660Irinotecan 622Leucovorin 575Pemetrexed 510Drug Therapy 493Cetuximab 483Trastuzumab 469Cytarabine 466Magnetic Resonance Spectroscopy 458Filgrastim 446Prednisone 433Lenalidomide 409Specimen Handling 408Temozolomide 400

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × Technetium Tc 99m Aggregated Albumin × Clear all
NCT02773238 2024-08-14

FLARE RT for Patients With Stage IIB-IIIB Non-small Cell Lung Cancer: Personalizing Radiation Therapy Using PET/CT and SPECT/CT Imaging

University of Washington

Phase 2 Completed
51 enrolled 14 charts
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT02050724 2017-02-02

ThoHSpEkt

Cantonal Hospital of St. Gallen

Phase 2 Terminated
11 enrolled
Thoracic

Bronchial Neoplasms, Solitary Pulmonary Nodule

Data powered by HemOnc (CC BY 4.0) Colophon âš¡